966-P: Real-World Impact of AI-driven CGM Platform on Glycemic Status in Type 2 Diabetes—A Retrospective Study
Introduction and Objective: Artificial intelligence (AI)-powered diabetes management platforms integrating CGM technology represent a promising advancement in healthcare. This study evaluates the effectiveness of AI-integrated SDRMP platform in improving glycemic control. Methods: A 100-day retrospective study of 1752 individuals (1357 male, 395 female; mean age 50.22±11.33 years) assessed the...
Introduction and Objective: Artificial intelligence (AI)-powered diabetes management platforms integrating CGM technology represent a promising advancement in healthcare. This study evaluates the effectiveness of AI-integrated SDRMP platform in improving glycemic control. Methods: A 100-day retrospective study of 1752 individuals (1357 male, 395 female; mean age 50.22±11.33 years) assessed the...
Machine-ingested summary: the claims above reflect a single primary source and have not been weighed against contradicting evidence by a Truvace editor yet.
Evidence
- Peer-reviewedDiabetes2025-06-13
How should this claim be treated?
Truvace Impact Record TRV-2026-0016, v2: “966-P: Real-World Impact of AI-driven CGM Platform on Glycemic Status in Type 2 Diabetes—A Retrospective Study.” Truvace, 2026-07-19. /record/TRV-2026-0016 (accessed at citation time). sha256 84fbf834aabcd4cf…
Calibration history
Every change to this record since certification, in the open.
Corrected automated sector classification after taxonomy audit
Certified into the record
How to verify without trusting this page
Fetch the canonical text of any version from /api/record/TRV-2026-0016 and hash it yourself — for example shasum -a 256 on the saved canonical field. The result must equal content_hash, and each version’s text ends with prev:followed by the prior version’s hash (version 1 chains to 64 zeros). If a single character of any version had been altered since certification, the chain would not reproduce.
ace